This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

China to open up government IP data for AI, commercial use

By MLex Staff ( August 28, 2026, 06:55 GMT | Insight) -- China will expand access to and commercial use of government-held intellectual-property data, using it to train industry-specific artificial intelligence models, support financing and corporate research and inform policymaking, under new guidelines aimed at unlocking its economic value. The country will steadily promote the development, training and deployment of industry-specific large AI models using IP data, according to guidelines jointly issued by the China National Intellectual Property Administration and the National Data Administration.China will expand access to and commercial use of government-held intellectual-property data, using it to train industry-specific artificial intelligence models, support financing and corporate research and inform policymaking, under new guidelines aimed at unlocking its economic value....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login